Antibe Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Mar 24 | BuyCA$10,000 | Daniel Legault | Individual | 20,000 | CA$0.50 | |
07 Mar 24 | BuyCA$7,800 | Scott Curtis | Individual | 15,000 | CA$0.52 | |
06 Mar 24 | BuyCA$12,970 | Joseph Stauffer | Individual | 24,000 | CA$0.54 |
Insider Trading Volume
Insider Buying: ATE insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 173,089 | 0.327% |
Institutions | 240,000 | 0.453% |
Individual Insiders | 1,636,495 | 3.09% |
General Public | 50,959,778 | 96.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,129,396 | CA$333.2k | 1.8% | no data | |||
254,819 | CA$75.2k | 33.3% | no data | |||
240,000 | CA$70.8k | 0% | no data | |||
173,089 | CA$51.1k | 69% | no data | |||
115,000 | CA$33.9k | 15% | no data | |||
68,918 | CA$20.3k | 0% | no data | |||
41,700 | CA$12.3k | 0% | no data | |||
26,662 | CA$7.9k | 0% | no data |